Eradicating H. pylori

Am J Gastroenterol. 2019 Dec;114(12):1827-1828. doi: 10.14309/ajg.0000000000000424.
No abstract available

MeSH terms

  • Adenocarcinoma / prevention & control
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Arrhythmias, Cardiac / chemically induced*
  • Clarithromycin / adverse effects
  • Clarithromycin / therapeutic use
  • Drug Therapy, Combination
  • Esophageal Neoplasms / prevention & control
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori
  • Humans
  • Mortality
  • Myocardial Infarction / chemically induced*
  • Patient Selection
  • Practice Guidelines as Topic
  • Quinolones / adverse effects
  • Quinolones / therapeutic use
  • Risk
  • Risk Assessment
  • Stomach Neoplasms / prevention & control*
  • United States

Substances

  • Anti-Bacterial Agents
  • Quinolones
  • Clarithromycin

Supplementary concepts

  • Adenocarcinoma Of Esophagus